Illnesses Tied to Omicron May Be Milder, Preliminary Study Suggests

The findings, which also show that the new variant partly dodges the Pfizer-BioNTech vaccine, are based on only three weeks of data. Epidemiologists cautioned that the full picture is still emerging.